What is the VXL.V share price today?

This page shows the latest available Vaxil Bio Ltd. (VXL.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.

Where is Vaxil Bio Ltd. listed?

Vaxil Bio Ltd. trades on the TSX Venture Exchange under the symbol VXL.V, ISIN CA92243L2066.

How large is Vaxil Bio Ltd.?

Its market capitalisation is approximately 597.6K CAD, based on the latest available price and share count from our data provider.

TSX Venture Exchange (TSXV) · VXL.V · ISIN CA92243L2066

Vaxil Bio Ltd.

0.1450 CAD

0(0.00%)

Previous close · Sep 17, 12:18 ET

Data last updated: Sep 17, 12:18 ET (2 d ago)· Delayed exchange data

Vaxil Bio Ltd. (VXL.V) trades on the TSX Venture Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 597.6K CAD. The company reports around 3 employees. Its ISIN is CA92243L2066. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

TSX Venture Exchange (TSXV)

ISIN

CA92243L2066

Sector

Healthcare

Industry

Biotechnology

Country

Market cap

577.68K CAD

Employees

Previous close

0.14 CAD

Day range

0.14 – 0.14

52-week range

0.13 – 0.29

Volume

500

50-day average

0.16 CAD

200-day average

0.17 CAD

Asset type

Equity

About Vaxil Bio Ltd.

Vaxil Bio Ltd. is a biotechnology firm dedicated to discovering and developing innovative therapeutic agents. Its foundation lies in a unique signal peptide-based platform, which it leverages to address critical health challenges, specifically infectious diseases and various cancers. The company's primary therapeutic candidate, ImMucin, has successfully advanced through Phase I/II clinical trials as a potential treatment for multiple myeloma. Beyond ImMucin, Vaxil Bio is actively developing a vaccine/treatment for tuberculosis, as well as a vaccine targeting coronavirus (COVID-19). Strategic alliances bolster its research efforts; Vaxil Bio collaborates with The Tel Aviv Sourasky Medical Center on a research initiative to create a peptide-based COVID-19 vaccine. Furthermore, it holds a Cooperative Research and Development Agreement with the U.S. Army Medical Research Institute of Infectious Diseases to assess CorVax's efficacy in preventing COVID-19 in murine models. Established in 2006, the company's operations are based in Toronto, Canada.

Company website

Frequently asked

What is the VXL.V share price today?: This page shows the latest available Vaxil Bio Ltd. (VXL.V) price with its change against the prior close. Values are delayed or previous-close, not real-time.
Where is Vaxil Bio Ltd. listed?: Vaxil Bio Ltd. trades on the TSX Venture Exchange under the symbol VXL.V, ISIN CA92243L2066.
How large is Vaxil Bio Ltd.?: Its market capitalisation is approximately 597.6K CAD, based on the latest available price and share count from our data provider.

All Vaxil Bio Ltd. data comes from exchange and provider feeds for the TSX Venture Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.